Plant Advanced Technologies SA (EPA:ALPAT)
France · Delayed Price · Currency is EUR 7.80
0.00 (0.00%)
At close: Jan 30, 2026
EPA:ALPAT Market Cap
EPA:ALPAT has a market cap or net worth of €8.75 million as of January 30, 2026. Its market cap has decreased by -33.06% in one year.
Market Cap
8.75M
Enterprise Value
12.73M
Revenue
2.22M
Ranking
n/a
PE Ratio
9.29
Stock Price
€7.80
Market Cap Chart
Since August 5, 2009, EPA:ALPAT's market cap has increased from 6.22M to 8.75M, an increase of 40.67%. That is a compound annual growth rate of 2.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 8.75M | -4.88% |
| Dec 31, 2025 | 9.20M | -30.22% |
| Dec 31, 2024 | 13.18M | 43.55% |
| Dec 29, 2023 | 9.18M | -36.37% |
| Dec 30, 2022 | 14.43M | -28.63% |
| Dec 31, 2021 | 20.23M | -10.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nicox | 32.87M |
| Aelis Farma | 29.90M |
| Advicenne | 24.48M |
| genOway Société anonyme | 23.33M |
| GenSight Biologics | 17.73M |
| NFL Biosciences | 16.25M |
| Poxel | 13.03M |
| Oncodesign Precision Medicine Société anonyme | 10.51M |